https://www.pharmaceutical-technology.com/news/theramex-gains-european-rights-to-duphaston-and-femoston-from-viatris/
Theramex has added the synthetic hormones to its portfolio as Viatris divests its businesses and sells assets.
theramexgainseuropeanrightsduphaston